Income Statement Quest Laboratories Limited

Stocks

QUESTLAB

INE0TNW01017

Pharmaceuticals

Market Closed - NSE India S.E. 04:35:10 21/08/2026 pm IST			5-day change	1st Jan Change
85.85 ^INR	-1.21%		-6.12%	-22.03%

13/02	Quest Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
13/11	Quest Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI

a39ca16722a97b3e28a9f.VBw_pKG6jxdqdMJv3Ulmo5_cBLskOi36H7XpHbz4HXk.DHtPz9uCxiNeF4EZrTAWxNDpcPNNV3uWVoSxadq9fkoDXl3dzO2-eS8DrQ

Published financial data: QUEST LABORATORIES LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	30Cr	59Cr	62Cr	83Cr	103.97Cr
Other Revenues, Total	-	-	-	-	1T
Total Revenues	30Cr	59Cr	62Cr	83Cr	103.97Cr
Cost of Goods Sold, Total	25Cr	45Cr	42Cr	52Cr	81Cr
Gross Profit	5.79Cr	15Cr	20Cr	30Cr	23Cr
Selling General & Admin Expenses, Total	2.41Cr	3.26Cr	3.59Cr	4.28Cr	4.33Cr
Depreciation & Amortization - (IS)	39.38L	46.03L	54.98L	56.78L	63.6L
Other Operating Expenses	1.84Cr	5.13Cr	8.17Cr	10Cr	1.36Cr
Other Operating Expenses, Total	4.65Cr	8.84Cr	12Cr	15Cr	6.32Cr
Operating Income	1.14Cr	6.04Cr	7.4Cr	15Cr	17Cr
Interest Expense, Total	-28.57L	-26.55L	-51.97L	-72.69L	-84.3L
Interest And Investment Income	1L	4L	10L	22.91L	2.59Cr
Net Interest Expenses	-27.35L	-22.66L	-42.22L	-49.78L	1.75Cr
Other Non Operating Income (Expenses)	-2L	-3L	-2L	-4L	-6L
EBT, Excl. Unusual Items	84.63L	5.79Cr	6.96Cr	14Cr	19Cr
Gain (Loss) On Sale Of Assets	16.69T	-	40T	-	-
EBT, Incl. Unusual Items	84.79L	5.79Cr	6.96Cr	14Cr	19Cr
Income Tax Expense	19.33L	1.62Cr	1.93Cr	4.35Cr	5.12Cr
Earnings From Continuing Operations	65.47L	4.17Cr	5.03Cr	10Cr	14Cr
Net Income to Company	65.47L	4.17Cr	5.03Cr	10Cr	14Cr
Net Income - (IS)	65.47L	4.17Cr	5.03Cr	10Cr	14Cr
Net Income to Common Incl Extra Items	65.47L	4.17Cr	5.03Cr	10Cr	14Cr
Net Income to Common Excl. Extra Items	65.47L	4.17Cr	5.03Cr	10Cr	14Cr
Per Share Items
Net EPS - Basic	0.61	3.86	4.66	8.46	8.28
Basic EPS - Continuing Operations	0.61	3.86	4.66	8.46	8.28
Basic Weighted Average Shares Outstanding	1.08Cr	1.08Cr	1.08Cr	1.19Cr	1.64Cr
Net EPS - Diluted	0.61	3.86	4.66	8.46	8.28
Diluted EPS - Continuing Operations	0.61	3.86	4.66	8.46	8.28
Diluted Weighted Average Shares Outstanding	1.08Cr	1.08Cr	1.08Cr	1.19Cr	1.64Cr
Normalized Basic EPS	0.49	3.35	4.03	7.56	7.13
Normalized Diluted EPS	0.49	3.35	4.03	7.56	7.13
Supplemental Items
EBITDA	1.53Cr	6.5Cr	7.95Cr	16Cr	18Cr
EBITA	1.14Cr	6.04Cr	7.4Cr	15Cr	17Cr
EBIT	1.14Cr	6.04Cr	7.4Cr	15Cr	17Cr
EBITDAR	1.54Cr	6.51Cr	7.96Cr	16Cr	18Cr
Total Revenues (As Reported)	30Cr	60Cr	62Cr	83Cr	108.21Cr
Effective Tax Rate - (Ratio)	22.79	27.99	27.75	30.13	27.39
Total Current Taxes	14.74L	1.55Cr	1.79Cr	4.21Cr	4.57Cr
Total Deferred Taxes	5L	7L	13.95L	14.54L	54.6L
Normalized Net Income	52.89L	3.62Cr	4.35Cr	9.03Cr	12Cr
Interest on Long-Term Debt	-	-	-	2.58T	84.26L
Non-Cash Pension Expense	-	-	2L	20T	-
Supplemental Operating Expense Items
Advertising Expense	5T	5T	41T	81.92T	4L
Selling and Marketing Expenses	5T	5T	41T	81.92T	4L
Net Rental Expense, Total	24.59T	1L	1L	24.59T	60T
Imputed Operating Lease Interest Expense	-	78.94T	2L	31.16T	22.9T
Imputed Operating Lease Depreciation	-	35.65T	-20.73T	-6.57T	37.1T
Maintenance & Repair Expenses, Total	12.43L	12.52L	12.59L	10.18L	7L

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	10.02L	6L	2.5Cr	14.36L	11.29L
Short Term Investments	-	-	-	-	48Cr
Trading Asset Securities, Total	-	-	-	-	1.71Cr
Total Cash And Short Term Investments	10.02L	6L	2.5Cr	14.36L	49Cr
Accounts Receivable, Total	9.15Cr	22Cr	20Cr	23Cr	30Cr
Other Receivables	1.32Cr	1.58Cr	2.02Cr	91.68L	71.9L
Notes Receivable	27.89L	13.55L	7L	9L	88T
Total Receivables	11Cr	24Cr	22Cr	24Cr	31Cr
Inventory	82.8L	1.09Cr	11Cr	16Cr	21Cr
Prepaid Expenses	2L	2L	2L	1L	1L
Other Current Assets, Total	15.44L	62.69L	36.13L	94.1L	5.46Cr
Total Current Assets	12Cr	26Cr	36Cr	42Cr	106.95Cr
Gross Property Plant And Equipment	8.15Cr	10Cr	13Cr	14Cr	16Cr
Accumulated Depreciation	-2.21Cr	-2.67Cr	-3.22Cr	-3.79Cr	-4.4Cr
Net Property Plant And Equipment	5.94Cr	7.38Cr	9.84Cr	10Cr	12Cr
Long-term Investments	9L	9L	9L	9L	2.92Cr
Loans Receivable Long-Term	8L	8L	-	8L	-
Other Long-Term Assets, Total	52.87L	1.92Cr	66.16L	7.28Cr	1T
Total Assets	18Cr	35Cr	47Cr	59Cr	121.65Cr
Liabilities
Accounts Payable, Total	7.97Cr	17Cr	25Cr	20Cr	5.73Cr
Accrued Expenses, Total	59.8L	1.27Cr	67.38L	85.58L	2.1Cr
Short-term Borrowings	-	-	-	3.85Cr	28Cr
Current Portion of Long-Term Debt	1.89Cr	1.79Cr	1.97Cr	-	41.69L
Current Income Taxes Payable	14.74L	1.55Cr	1.5Cr	4.21Cr	28.18L
Other Current Liabilities	43.7L	1.5Cr	7L	12.81L	16.36L
Total Current Liabilities	11Cr	23Cr	29Cr	29Cr	37Cr
Long-Term Debt	1.15Cr	1.33Cr	2.13Cr	1.23Cr	1.36Cr
Pension & Other Post Retirement Benefits	-	-	9L	-	-
Deferred Tax Liability Non Current	40.98L	47.49L	59.84L	76.54L	1.31Cr
Other Non Current Liabilities	-	-	-	-	-
Total Liabilities	13Cr	25Cr	32Cr	31Cr	40Cr
Common Stock, Total	1.08Cr	1.08Cr	1.08Cr	12Cr	16Cr
Additional Paid In Capital	1.6Cr	1.6Cr	1.6Cr	2.3Cr	37Cr
Retained Earnings	3.21Cr	7.38Cr	12Cr	14Cr	28Cr
Comprehensive Income and Other	-	-	-	-	-
Total Common Equity	5.89Cr	10Cr	15Cr	29Cr	82Cr
Total Equity	5.89Cr	10Cr	15Cr	29Cr	82Cr
Total Liabilities And Equity	18Cr	35Cr	47Cr	59Cr	121.65Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.08Cr	1.08Cr	1.08Cr	1.19Cr	1.64Cr
ECS Total Common Shares Outstanding	1.08Cr	1.08Cr	1.08Cr	1.19Cr	1.64Cr
Book Value / Share	5.46	9.32	13.93	23.99	49.92
Tangible Book Value	5.89Cr	10Cr	15Cr	29Cr	82Cr
Tangible Book Value Per Share	5.46	9.32	13.93	23.99	49.92
Total Debt	3.04Cr	3.13Cr	4.1Cr	5.08Cr	30Cr
Net Debt	2.94Cr	3.06Cr	1.6Cr	4.94Cr	-19Cr
Debt Equivalent Oper. Leases	2L	9L	10.96L	2L	5L
Account Code - Inventory Valuation	-	5	6	5	5
Inventories - Raw Materials, Total	50.6L	98.49L	11Cr	16Cr	17Cr
Inventories - Work In Process, Total	-	-	-	-	1Cr
Inventories - Finished Goods, Total	32.2L	10.23L	2L	7L	3.19Cr
Land - (BS)	10.43L	10.43L	10.43L	10.43L	72.73L
Buildings, Total	4.04Cr	5.31Cr	6.82Cr	7.34Cr	7.31Cr
Machinery, Total	4Cr	4.63Cr	6.14Cr	6.56Cr	8.15Cr
Full Time Employees	-	-	84	74	50

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	65.47L	4.17Cr	5.03Cr	10Cr	14Cr
Depreciation & Amortization - CF	39.38L	46.03L	54.98L	56.78L	63.6L
Depreciation & Amortization, Total	39.38L	46.03L	54.98L	56.78L	63.6L
(Gain) Loss From Sale Of Asset	-16.69T	3L	-40T	-	-
Other Operating Activities, Total	48.82L	11.48L	83.14L	68.02L	-2.3Cr
Change In Accounts Receivable	-1.81Cr	-13Cr	2.12Cr	-3.47Cr	-5.6Cr
Change In Inventories	3.41Cr	-25.92L	-10Cr	-4.97Cr	-5.25Cr
Change In Accounts Payable	-1.54Cr	9.08Cr	7.56Cr	-4.99Cr	-18Cr
Change in Other Net Operating Assets	8L	2.47Cr	-2.38Cr	5.1Cr	-6.06Cr
Cash from Operations	1.68Cr	3.15Cr	3.63Cr	3.01Cr	-23Cr
Capital Expenditure	-	-1.93Cr	-3.07Cr	-93.99L	-3.47Cr
Sale of Property, Plant, and Equipment	1.21Cr	55T	-	-	-
Investment in Marketable and Equity Securities, Total	-	-	-	-	-44Cr
Other Investing Activities, Total	25.82L	-1.21Cr	10L	-4.09Cr	3.24Cr
Cash from Investing	1.46Cr	-3.14Cr	-2.97Cr	-5.03Cr	-44Cr
Short Term Debt Issued, Total	-	-	17.94L	-	25Cr
Long-Term Debt Issued, Total	5L	-	79.21L	-	45.77L
Total Debt Issued	5L	-	97.15L	-	25Cr
Long-Term Debt Repaid, Total	-	-	-	-64.66L	-
Total Debt Repaid	-	-	-	-64.66L	-
Issuance of Common Stock	-	-	-	3.45Cr	43Cr
Other Financing Activities, Total	-29.49L	-5L	-70.48L	-76.39L	-90.56L
Cash from Financing	-24.72L	-5L	26.67L	2.04Cr	67Cr
Miscellaneous Cash Flow Adjustments	-2.93Cr	-1	-	-	-16.45L
Net Change in Cash	-3L	-4L	92.77L	2L	-3L
Supplemental Items
Cash Interest Paid	30.71L	9L	53.84L	76.39L	90.55L
Cash Income Tax Paid (Refund)	-	1.55Cr	1.56Cr	4.21Cr	4.09Cr
Levered Free Cash Flow	-	61.86L	-81.98L	-1.42Cr	-25Cr
Unlevered Free Cash Flow	-	78.45L	-49.5L	-96.85L	-24Cr
Change In Net Working Capital	-	1.52Cr	2.6Cr	9.96Cr	32Cr
Net Debt Issued / Repaid	5L	-	97.15L	-64.66L	25Cr

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	-	14.11	11.35	17.63	11.66
Return on Total Capital	-	34.17	28.68	35.38	14.57
Return On Equity %	-	52.26	40.2	46.15	24.56
Return on Common Equity	-	52.26	40.2	46.15	24.56
Margin Analysis
Gross Profit Margin %	19.06	25.03	31.96	36.6	22.43
SG&A Margin	7.94	5.48	5.82	5.19	4.16
EBITDA Margin %	5.06	10.93	12.89	18.83	16.96
EBITA Margin %	3.76	10.16	12	18.14	16.35
EBIT Margin %	3.76	10.16	12	18.14	16.35
Income From Continuing Operations Margin %	2.16	7	8.16	12.23	13.05
Net Income Margin %	2.16	7	8.16	12.23	13.05
Net Avail. For Common Margin %	2.16	7	8.16	12.23	13.05
Normalized Net Income Margin	1.74	6.08	7.05	10.94	11.23
Levered Free Cash Flow Margin	-	1.04	-1.33	-1.72	-23.75
Unlevered Free Cash Flow Margin	-	1.32	-0.8	-1.17	-23.24
Asset Turnover
Asset Turnover	-	2.22	1.51	1.55	1.14
Fixed Assets Turnover	-	8.94	7.16	8.24	9.44
Receivables Turnover (Average Receivables)	-	3.81	2.94	3.81	3.82
Inventory Turnover (Average Inventory)	-	46.57	6.85	3.84	4.3
Short Term Liquidity
Current Ratio	1.07	1.1	1.25	1.45	2.88
Quick Ratio	0.96	1.02	0.85	0.85	2.15
Operating Cash Flow to Current Liabilities	0.15	0.14	0.13	0.11	-0.63
Days Sales Outstanding (Average Receivables)	-	95.77	124.35	96.08	95.62
Days Outstanding Inventory (Average Inventory)	-	7.84	53.28	95.37	84.84
Average Days Payable Outstanding	-	101.77	146.14	141.17	56
Cash Conversion Cycle (Average Days)	-	1.84	31.49	50.27	124.47
Long Term Solvency
Total Debt/Equity	51.63	31.08	27.27	17.74	36.99
Total Debt / Total Capital	34.05	23.71	21.43	15.07	27
LT Debt/Equity	19.6	13.28	14.16	4.29	1.66
Long-Term Debt / Total Capital	12.93	10.13	11.12	3.65	1.21
Total Liabilities / Total Assets	68.15	71.3	67.8	51.69	32.75
EBIT / Interest Expense	3.99	22.76	14.23	20.61	20.16
EBITDA / Interest Expense	5.37	24.5	15.29	21.39	20.92
(EBITDA - Capex) / Interest Expense	5.37	17.22	9.39	20.1	16.8
Total Debt / EBITDA	1.98	0.48	0.52	0.33	1.72
Net Debt / EBITDA	1.92	0.47	0.2	0.32	-1.08
Total Debt / (EBITDA - Capex)	1.98	0.68	0.84	0.35	2.14
Net Debt / (EBITDA - Capex)	1.92	0.67	0.33	0.34	-1.35
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	95.91	3.63	33.94	25.92
Gross Profit, 1 Yr. Growth %	-	157.28	32.52	53.25	-19
EBITDA, 1 Yr. Growth %	-	323.67	22.06	95.13	13.3
EBITA, 1 Yr. Growth %	-	429.53	22.25	101.94	13.35
EBIT, 1 Yr. Growth %	-	429.53	22.25	101.94	13.35
Earnings From Cont. Operations, 1 Yr. Growth %	-	536.37	22.5	100.08	34.4
Net Income, 1 Yr. Growth %	-	536.37	22.5	100.08	34.4
Normalized Net Income, 1 Yr. Growth %	-	583.61	20.08	107.03	29.34
Diluted EPS Before Extra, 1 Yr. Growth %	-	536.37	22.5	80.83	34.4
Accounts Receivable, 1 Yr. Growth %	-	140.99	-9.63	17.41	22.86
Inventory, 1 Yr. Growth %	-	31.31	926.23	44.51	32.53
Net Property, Plant and Equip., 1 Yr. Growth %	-	24.24	33.41	3.78	15.12
Total Assets, 1 Yr. Growth %	-	89.5	34.05	26.31	100.95
Tangible Book Value, 1 Yr. Growth %	-	70.75	50.31	89.7	185.35
Common Equity, 1 Yr. Growth %	-	70.75	50.31	89.7	185.35
Cash From Operations, 1 Yr. Growth %	-	87.34	5.08	-22.33	-874.08
Capital Expenditures, 1 Yr. Growth %	-	-	58.86	-68.81	269.33
Levered Free Cash Flow, 1 Yr. Growth %	-	-	-232.21	87.95	1.08T
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-	-162.6	119.72	1.37T
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	-	42.52	17.81	29.87
Gross Profit, 2 Yr. CAGR %	-	-	84.7	42.57	8.75
EBITDA, 2 Yr. CAGR %	-	-	133.79	54.54	48.76
EBITA, 2 Yr. CAGR %	-	-	164.16	57.36	51.37
EBIT, 2 Yr. CAGR %	-	-	164.16	57.36	51.37
Earnings From Cont. Operations, 2 Yr. CAGR %	-	-	177.08	56.81	63.99
Net Income, 2 Yr. CAGR %	-	-	177.08	56.81	63.99
Normalized Net Income, 2 Yr. CAGR %	-	-	197.14	57.92	63.64
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-	177.08	49.07	33.06
Accounts Receivable, 2 Yr. CAGR %	-	-	47.58	3.01	22.73
Inventory, 2 Yr. CAGR %	-	-	267.08	285.09	38.39
Net Property, Plant and Equip., 2 Yr. CAGR %	-	-	28.74	17.67	9.45
Total Assets, 2 Yr. CAGR %	-	-	59.24	30.53	60.98
Tangible Book Value, 2 Yr. CAGR %	-	-	59.72	69.3	132.76
Common Equity, 2 Yr. CAGR %	-	-	59.72	69.3	132.76
Cash From Operations, 2 Yr. CAGR %	-	-	86.2	-6.61	145.21
Capital Expenditures, 2 Yr. CAGR %	-	-	59.41	-30.23	7.32
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	-	51.48	471.11
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	-	10.67	640.42
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	-	39.58	20.46
Gross Profit, 3 Yr. CAGR %	-	-	-	73.49	16.19
EBITDA, 3 Yr. CAGR %	-	-	-	116.37	39.4
EBITA, 3 Yr. CAGR %	-	-	-	135.9	41.11
EBIT, 3 Yr. CAGR %	-	-	-	135.9	41.11
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	-	148.89	48.95
Net Income, 3 Yr. CAGR %	-	-	-	148.89	48.95
Normalized Net Income, 3 Yr. CAGR %	-	-	-	157.48	47.75
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	-	140.63	29.58
Accounts Receivable, 3 Yr. CAGR %	-	-	-	36.74	10.83
Inventory, 3 Yr. CAGR %	-	-	-	169.03	169.87
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	-	19.82	16.92
Total Assets, 3 Yr. CAGR %	-	-	-	47.47	51.77
Tangible Book Value, 3 Yr. CAGR %	-	-	-	69.44	101.53
Common Equity, 3 Yr. CAGR %	-	-	-	69.44	101.53
Cash From Operations, 3 Yr. CAGR %	-	-	-	21.47	89
Capital Expenditures, 3 Yr. CAGR %	-	-	-	-7.99	21.6
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-	69.91	241.48
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-	105.57	212.65
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	-	31.56
Gross Profit, 5 Yr. CAGR %	-	-	-	-	39.89
EBITDA, 5 Yr. CAGR %	-	-	-	-	75.36
EBITA, 5 Yr. CAGR %	-	-	-	-	88.14
EBIT, 5 Yr. CAGR %	-	-	-	-	88.14
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	-	116.35
Net Income, 5 Yr. CAGR %	-	-	-	-	116.35
Normalized Net Income, 5 Yr. CAGR %	-	-	-	-	113.71
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	-	99.04
Accounts Receivable, 5 Yr. CAGR %	-	-	-	-	32.54
Inventory, 5 Yr. CAGR %	-	-	-	-	38.19
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	-	17.84
Total Assets, 5 Yr. CAGR %	-	-	-	-	44.75
Tangible Book Value, 5 Yr. CAGR %	-	-	-	-	73.3
Common Equity, 5 Yr. CAGR %	-	-	-	-	73.3
Cash From Operations, 5 Yr. CAGR %	-	-	-	-	81.43
Capital Expenditures, 5 Yr. CAGR %	-	-	-	-	36.53